Corrigendum to: “Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study” [Atherosclerosis (Supplements) 30C (2017) 86–91]

• Claudia Stefanutti,
• Fabio Mazza,
• Dario Mesce,
• Claudia Morozzi,
• Serafina Di Giacomo,
• Marco Vitale,
• Mario Pergolini

Affiliations

Claudia Stefanutti

Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy; Corresponding author. Extracorporeal Therapeutic Techniques Unit, Lipid Clinic and Atherosclerosis Prevention Centre, Immunohematology and Transfusion Medicine, Department of Molecular Medicine, ‘Sapienza’ University of Rome, ‘Umberto I’ Hospital, 155, Viale del Policlinico, Rome, Italy.

Fabio Mazza

Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy

Dario Mesce

Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy

Claudia Morozzi

Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy

Serafina Di Giacomo

Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy

Marco Vitale

Extracorporeal Therapeutic Techniques, Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine, University of Rome‘Sapienza’, Umberto I Hospital, Rome, Italy

Mario Pergolini

Department of Internal Medicine and Medical Specialties, University of Rome ‘Sapienza’, Umberto I Hospital, Rome, Italy